Login to Your Account

Wangling With Border Issues

Canadian Companies Needing Mid-Level Funds Might Try U.S.

By Aaron Lorenzo

Monday, February 14, 2005

VANCOUVER, British Columbia - For maturing Canadian biotech firms, an inherent financing difficulty is the lack of available mezzanine-level funding in their country. Although that can be overcome by attracting U.S. venture capitalists, that sometimes is easier said than done.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription